Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
Abstract Background The opening of pannexin1 channels is considered as a key event in inflammation. Pannexin1 channel-mediated release of adenosine triphosphate triggers inflammasome signaling and activation of immune cells. By doing so, pannexin1 channels play an important role in several inflammat...
Main Authors: | Raf Van Campenhout, Timo W. M. De Groof, Prashant Kadam, Brenda R. Kwak, Serge Muyldermans, Nick Devoogdt, Mathieu Vinken |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-02137-1 |
Similar Items
-
Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor
by: Raf Van Campenhout, et al.
Published: (2021-01-01) -
Pannexin1 channels in the liver: an open enemy
by: Raf Van Campenhout, et al.
Published: (2023-07-01) -
Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels
by: Anne Caufriez, et al.
Published: (2022-05-01) -
Connexin and pannexin (hemi)channels in the liver
by: Michaël eMaes, et al.
Published: (2014-01-01) -
The Role of Connexin and Pannexin Channels in Perinatal Brain Injury and Inflammation
by: Kelly Q. Zhou, et al.
Published: (2019-02-01)